Maverick Minute

Executive Order_adobe_express

06/15/25

Trump Administration Healthcare Leadership Update

The Trump administration is prioritizing health policy innovation by appointing leaders with strong technology backgrounds.

Price transparency Graphic

06/15/25

CMS Health Tech RFI Listening Session

Following the publication of its Health Technology RFI, CMS gathered industry stakeholders to discuss the health technology ecosystem and announce five new technology-focused initiatives.

What Makes Maverick Unique

06/6/25

Prescription Drug Price Transparency Request for Information

After several years of enforcement discretion, HHS, the Department of Labor (DOL), and the Treasury (the “tri-agencies”) are asking for public input on how health plans can publicly post the prices of prescription drugs.

Price transparency Graphic

05/25/25

Peterson Health Technology Institute (PHTI): Virtual Solutions for Depression and Anxiety

PHTI found that digital mental health tools offer clinical benefit but vary in cost-effectiveness.

Payers and Provider Graphics

05/16/25

CMMI’s New Strategy

The agency that tests alternative payment models in Medicare and Medicaid released a new guiding strategy, replacing the old CMMI Second Decade Refresh.

Health illustrations by Storyset

04/30/25

Trump Administration’s Drug Pricing Executive Order

President Trump issued an EO intended to lower prescription drug prices.

Health illustrations by Storyset

04/27/25

Sequoia Project’s Payer-to-Payer API Checklist

The Sequoia Project created a checklist to help payers implement required APIs that allow them to exchange data with other payers.

the-capital

04/27/25

The Health Tech Investment Act

The Health Tech Investment Act introduces a formal Medicare reimbursement pathway for FDA-cleared AI-enabled medical technologies.

Price transparency Graphic

04/20/25

“Charting the Future of Biotechnology” – A Call to Action from A Congressional Commission

The National Security Commission on Emerging Biotechnology released an action plan to improve U.S. biotech innovation as the competition with China intensifies.

Price transparency Graphic

04/19/25

CMS Drops AI Guardrails from Final MA Rule

CMS finalized the 2026 Medicare Advantage and Part D rule but did not adopt new restrictions on the use of AI in prior authorization.